Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionCAPROCK Group, Inc.
Latest Disclosed Ownership76,903 shares
Latest Disclosed Value $ 10,718,080
CAPROCK Group, Inc. reports 0.04% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 11, 2026 - CAPROCK Group, Inc. filed a 13F-HR form disclosing ownership of 76,903 shares of Gilead Sciences, Inc. (CH:GILD) valued at $10,718,080 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 28, 2026 disclosing 76,931 shares of Gilead Sciences, Inc.. This represents a change in shares of -0.04% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F GILEAD SCIENCES COM 375558103 76,903 -28 -0.04 10,718 13.51 0.2602
2026-01-28 2025-12-31 13F GILEAD SCIENCES COM 375558103 76,931 12,895 20.14 9,443 30.52 0.1995
2025-11-06 2025-09-30 13F GILEAD SCIENCES COM 375558103 64,036 14,591 29.51 7,234 30.58 0.1782
2025-05-15 2025-03-31 13F GILEAD SCIENCES COM 375558103 49,445 7,076 16.70 5,540 41.58 0.1690
2025-01-23 2024-12-31 13F GILEAD SCIENCES COM 375558103 42,369 3,970 10.34 3,914 21.56 0.1279
2024-11-07 2024-09-30 13F GILEAD SCIENCES COM 375558103 38,399 -1,778 -4.43 3,219 16.80 0.1171
2024-08-06 2024-06-30 13F GILEAD SCIENCES COM 375558103 40,177 12,286 44.05 2,757 34.90 0.1121
2024-04-29 2024-03-31 13F GILEAD SCIENCES COM 375558103 27,891 687 2.53 2,043 -7.26 0.1171
2024-01-18 2023-12-31 13F GILEAD SCIENCES COM 375558103 27,204 40 0.15 2,204 8.26 0.1408
2023-10-18 2023-09-30 13F GILEAD SCIENCES COM 375558103 27,164 -1,782 -6.16 2,036 -8.74 0.1540
2023-08-10 2023-06-30 13F GILEAD SCIENCES COM 375558103 28,946 623 2.20 2,231 -5.11 0.1638
2023-04-26 2023-03-31 13F GILEAD SCIENCES COM 375558103 28,323 1,855 7.01 2,350 3.43 0.1821
2023-01-23 2022-12-31 13F GILEAD SCIENCES COM 375558103 26,468 67 0.25 2,272 39.47 0.2115
2022-11-07 2022-09-30 13F GILEAD SCIENCES COM 375558103 26,401 2,943 12.55 1,629 12.34 0.1569
2022-07-26 2022-06-30 13F GILEAD SCIENCES COM 375558103 23,458 3,087 15.15 1,450 19.74 0.1422
2022-04-12 2022-03-31 13F GILEAD SCIENCES COM 375558103 20,371 753 3.84 1,211 -15.02 0.1138
2022-01-18 2021-12-31 13F GILEAD SCIENCES COM 375558103 19,618 -1,174 -5.65 1,425 -1.86 0.1175
2021-10-07 2021-09-30 13F GILEAD SCIENCES COM 375558103 20,792 -1,890 -8.33 1,452 -7.04 0.1298
2021-08-13 2021-06-30 13F GILEAD SCIENCES COM 375558103 22,682 10,329 83.62 1,562 95.74 0.1421
2021-04-29 2021-03-31 13F GILEAD SCIENCES COM 375558103 12,353 4,060 48.96 798 65.22 0.0873
2021-01-29 2020-12-31 13F GILEAD SCIENCES COM 375558103 8,293 -5,666 -40.59 483 -45.24 0.0551
2020-10-29 2020-09-30 13F GILEAD SCIENCES COM 375558103 13,959 -12,871 -47.97 882 -57.27 0.1207
2020-08-05 2020-06-30 13F GILEAD SCIENCES COM 375558103 26,830 4,061 17.84 2,064 21.27 0.3101
2020-04-28 2020-03-31 13F GILEAD SCIENCES COM 375558103 22,769 15,103 197.01 1,702 241.77 0.3223
2020-02-04 2019-12-31 13F GILEAD SCIENCES COM 375558103 7,666 -957 -11.10 498 -8.96 0.0891
2019-10-31 2019-09-30 13F GILEAD SCIENCES COM 375558103 8,623 714 9.03 547 2.43 0.1068
2019-07-23 2019-06-30 13F GILEAD SCIENCES COM 375558103 7,909 2,452 44.93 534 50.42 0.1044
2019-04-12 2019-03-31 13F GILEAD SCIENCES COM 375558103 5,457 678 14.19 355 18.73 0.0690
2019-01-29 2018-12-31 13F GILEAD SCIENCES COM 375558103 4,779 247 5.45 299 -14.57 0.0688
2018-10-17 2018-09-30 13F GILEAD SCIENCES COM 375558103 4,532 -435 -8.76 350 -0.57 0.0712
2018-07-23 2018-06-30 13F GILEAD SCIENCES COM 375558103 4,967 899 22.10 352 14.66 0.0744
2018-04-23 2018-03-31 13F GILEAD SCIENCES COM 375558103 4,068 12 0.30 307 -4.36 0.0655
2018-01-17 2017-12-31 13F GILEAD SCIENCES COM 375558103 4,056 -982 -19.49 321 -21.32 0.0625
2017-10-23 2017-09-30 13F GILEAD SCIENCES COM 375558103 5,038 499 10.99 408 27.10 0.0850
2017-07-27 2017-06-30 13F GILEAD SCIENCES COM 375558103 4,539 -6,999 -60.66 321 -59.06 0.0713
2017-04-21 2017-03-31 13F GILEAD SCIENCES COM 375558103 11,538 -228 -1.94 784 -7.00 0.1842
2017-01-24 2016-12-31 13F GILEAD SCIENCES COM 375558103 11,766 -819 -6.51 843 -15.36 0.2121
2016-11-15 2016-09-30 13F GILEAD SCIENCES COM 375558103 12,585 6,409 103.77 996 93.40 0.2259
2016-08-25 2016-06-30 13F GILEAD SCIENCES COM 375558103 6,176 -1,441 -18.92 515 -26.43 0.1256
2016-05-11 2016-03-31 13F GILEAD SCIENCES COM 375558103 7,617 7,617 0.00 700 0.1660
2015-11-10 2015-09-30 13F GILEAD SCIENCES COM 375558103 0 -4,967 -100.00 0 -100.00
2015-08-12 2015-06-30 13F GILEAD SCIENCES COM 375558103 4,967 1,208 32.14 582 57.72 0.5332
2015-05-08 2015-03-31 13F GILEAD SCIENCES COM 375558103 3,759 0 0.00 369 4.24 0.3771
2015-02-06 2014-12-31 13F GILEAD SCIENCES COM 375558103 3,759 3,759 354 0.3838
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.